Randomized prospective phase II study of temsirolimus with or without low-dose interferon alpha in metastatic non-clear renal cell carcinoma: GOIRC study 02/2008
Read time: 1 mins
Last updated:10th Jul 2008
The main objective of this trial is to assess Overall Response Rate (RECIST Criteria); Time to Progression (TTP); Safety; Overall Survival (OS).
|Study start date||2008-07-10|